Changes in SOLACI Authorities During SOLACI-SBHCI 2023 Congress

After a successful scientific event where all the most important topics in current interventional cardiology were addressed, there was a change in the authorities of the Latin American Society of Interventional Cardiology for the 2023-2025 term.

In this sense, Dr. Mario Araya (Chile)—a prestigious interventional cardiologist in our region, former Sessions Director, member of the SOLACI-LATAM Bif Registry and President of the Department of Hemodynamics of the Chilean Society of Cardiology (SOCHICAR) for 6 years—took the office of the SOLACI Presidency during the closing ceremony of the SOLACI-SBHCI 2023 Congress. He follows the successful work headed by Dr. Anibal Damonte, who led SOLACI with great effort and dedication over the past two years—a period marked by the end of the COVID-19 pandemic and the return to face-to-face events.

During his administration, Dr. Damonte led this return to face-to-face attendance at the SOLACI-SOCIME 2022 Congress, strengthened SOLACI’s links with regional and international institutions, enhanced our research records, and facilitated numerous educational and institutional activities, among which we can highlight the educational Webinars, the “MILs Train More MILs” Program, regional conferences in different Latin American countries, and the launching of the SOLACI Postgraduate Course in Hemodynamics for Technicians and Nurses. 

Dr. Araya—who worked side by side with Dr. Damonte over the past two years as SOLACI Vice-President—will ensure the continuity of all SOLACI projects, joined by Dr. Ricardo Costa (BRA) as Vice-President and Dr. Pedro Hidalgo (Venezuela) and Dr. Omar Santaera (Argentina), who remain in their roles as Secretary and Treasurer, respectively.

SOLACI will continue strengthening its institutional projects over time, fulfilling its mission to promote and expand continuing medical education in interventional cardiology in our continent.

We wish the best to the new Board of Directors!


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

ACC 2026: SURViV Trial Results – Exclusive Presentation and Analysis with Dr. Dimytri Siqueira

Following the presentation of the SURViV trial in the Late Breaking Clinical Trials sessions at the American College of Cardiology Congress, Dr. Dimytri Siqueira...

SOLACI Technicians Webinar – Ultrasound Pulses + Calcium = Coronary Lithotripsy

The Latin American Society of Interventional Cardiology (SOLACI) invites you to participate in a new Live SOLACI Webinar specially designed for technicians, nurses, and...

COMPLICAT 2026: Collaborative learning to address complications in congenital and structural heart disease

Free online course in Spanish5 webinars in 2026 COMPLICAT 2026 returns with its second edition, consolidating itself as an innovative academic space dedicated to the...

CHIP LATAM | Chapter 2 – Mexico: Complications Workshop

The Latin American Society of Interventional Cardiology invites the entire medical community to participate in a virtual workshop on complications organized by SOLACI’s Complex...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | CHIP-BCIS3: Impella use as support in high-risk complex PCI

The use of percutaneous ventricular support during high-risk complex PCI has been proposed as a strategy to prevent hemodynamic deterioration in patients with severe...

ACC 2026 | ORBITA-CTO: PCI in chronic total occlusions and stable angina — the randomized trial we were missing?

Percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) remains a topic of ongoing debate in stable angina, with persistent uncertainty regarding its role...

ACC 2026 | FAST III: vFFR vs FFR in physiology-guided revascularization of intermediate coronary lesions

Physiological assessment of intermediate coronary lesions remains a cornerstone in decision-making for coronary revascularization. Although FFR continues to be one of the guideline-recommended references,...